FDA Clearance Tracker · K203084
Ablamap Software
Last checked: Nov 20, 2026Latest source record: Aug 31, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Aug 31, 2021
Substantially Equivalent
Time to decision
322 days
Received Oct 13, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K203084
- Device name
- Ablamap Software
- Applicant
- Ablacon, Inc.
- Applicant location
- Denver, CO
- Received
- Oct 13, 2020
- Decided
- Aug 31, 2021
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Computer, Diagnostic, Programmable (DQK)
- Device class
- Class II
- Regulation
- 21 CFR 870.1425
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DQK. The earliest in FDA's data is K760767, decided Oct 13, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K203084
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Ablacon, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Ablamap® System510(k)
K230008 · Decided Jun 8, 2023 · 156 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
K223666 · Decided Mar 17, 2023 · 100 days after receipt
Device type: Catheter, Intracardiac Mapping, High-Density Array (MTD) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.